✦ LIBER ✦

T1/T2 Glottic Cancer Managed by External Beam Radiotherapy: The Influence of Pretreatment Hemoglobin on Local Control

✍ Scribed by Padraig Warde; Brian O’Sullivan; Robert G Bristow; Tony Panzarella; Thomas J Keane; Patrick J Gullane; Ian P Witterick; David Payne; Fei-Fei Liu; Michael McLean; John Waldron; Bernard J Cummings

Book ID: 108437112
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 107 KB
Volume: 41
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(98)00062-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

40 Pretreatment hemoglobin level influen

40 Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx

✍ Kiaran P. McGee; Douglas A. Fein; W. Robert Lee; Alexandra L. Hanlon; John A. Ri 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 104 KB

T1–T2 squamous cell carcinoma of the glo

T1–T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: A multivariate analysis of variables potentially influencing local control

✍ Douglas A. Fein; William M. Mendenhall; James T. Parsons; Rodney R. Million 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 219 KB

783 Poster Performance status, pretreatm

783 Poster Performance status, pretreatment and mean haemoglobin levels influences local control and survival of T1-T3N0 squamous cell carcinomas of the glottic larynx treated exclusively with radiotherapy and curative intent

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 152 KB

The influence of local control on metast

The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy

✍ Gunar K. Zagars; Andrew C. Von Eschenbach; Alberto G. Ayala; Timothy E. Schulthe 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 722 KB

The influence of local control on metastatic dissemination was analyzed in 601 patients with clinically staged A2 to C prostate cancer treated by high-energy external beam radiation therapy who did not undergo hormonal manipulation before disease progression. Median follow-up for surviving patients